Five Prime Therapeutics started at neutral with $19 stock price target at J.P. Morgan

1 News Net

1 News - 1 Movies - 1 Music - 1 eBooks - 1 Search

 

1 News Net

1 News - 1 Movies - 1 Music - 1 eBooks - 1 Search

 

Leave a Reply